Trial intelligence / Profile preview

Evaluation of [11C]JMJ-129-d2 for PDE4D Imaging in Healthy Volunteers

NCT07853781Phase 1Recruiting

Sponsor
National Institute of Mental Health
Start
Nov 2026
Primary completion
Feb 2030
Countries
1
01

Overview

Phase 1, open-label, single-arm trial of [11C]JMJ-129-d2, sponsored by National Institute of Mental Health. Primary endpoint: Total Volume of Distribution at 120 months. Started Nov 2026; status: recruiting.

02

Drugs

[11C]JMJ-129-d2

Beyond the preview

Go deeper on NCT07853781.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07853781.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call